Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 97
Filter
Add more filters










Publication year range
1.
J Mech Behav Biomed Mater ; 55: 104-119, 2015 Mar.
Article in English | MEDLINE | ID: mdl-26580023

ABSTRACT

The torsional behaviour of the heart (i.e. the mutual rotation of the cardiac base and apex) was proved to be sensitive to alterations of some cardiovascular parameters, i.e. preload, afterload and contractility. Moreover, pathologies which affect the fibers architecture and cardiac geometry were proved to alter the cardiac torsion pattern. For these reasons, cardiac torsion represents a sensitive index of ventricular performance. The aim of this work is to provide further insight into physiological and pathological alterations of the cardiac torsion by means of computational analyses, combining a structural model of the two ventricles with simple lumped parameter models of both the systemic and the pulmonary circulations. Starting from diagnostic images, a 3D anatomy based geometry of the two ventricles was reconstructed. The myocytes orientation in the ventricles was assigned according to literature data and the myocardium was modelled as an anisotropic hyperelastic material. Both the active and the passive phases of the cardiac cycle were modelled, and different clinical conditions were simulated. The results in terms of alterations of the cardiac torsion in the presence of pathologies are in agreement with experimental literature data. The use of a computational approach allowed the investigation of the stresses and strains in the ventricular wall as well as of the global hemodynamic parameters in the presence of the considered pathologies. Furthermore, the model outcomes highlight how for specific pathological conditions, an altered torsional pattern of the ventricles can be present, encouraging the use of the ventricular torsion in the clinical practice.


Subject(s)
Heart Diseases/pathology , Mechanical Phenomena , Models, Anatomic , Myocardium/pathology , Biomechanical Phenomena , Finite Element Analysis , Heart Diseases/physiopathology , Hemodynamics , Rotation , Stress, Physiological
2.
J Matern Fetal Neonatal Med ; 26(8): 833-40, 2013 May.
Article in English | MEDLINE | ID: mdl-23205867

ABSTRACT

OBJECTIVE: While propranolol pharmacokinetics has been extensively studied in adults, this study reports the first evaluation of propranolol pharmacokinetics in term and preterm neonates. METHODS: Propranolol concentrations were measured in four term and 32 preterm newborns treated with oral propranolol at the dose of 0.5 or 0.25 mg/kg every 6 h by serial dried blood spots. RESULTS: The levels of propranolol, although with high inter-individual variability, were proportional with the administered dose. Pharmacokinetic parameters evaluated at the steady state in newborns treated with 0.5 mg/kg/6 h showed values of maximal (71.7 ± 29.8 ng/mL), minimal (42.2 ± 20.8 ng/mL) and average concentration (60.8 ± 25.0 ng/mL), time of maximal concentration (2.6 ± 0.9 h) and area under the time-concentration curve (364.7 ± 150.2 ng/mL/h) similar to those observed in adults. In both dosing groups, elimination half-life was significantly longer (14.9 ± 4.3 and 15.9 ± 6.1 h), and apparent total body clearance (27.2 ± 13.9 and 31.3 ± 13.3 mL/kg/min) lower than those reported in adults, suggesting a slower metabolism in newborns. No differences were observed between newborns with different gestational age or different sex. CONCLUSIONS: Neonates treated with propranolol-exhibited drug concentrations proportional with the dose, with significant long half-life.


Subject(s)
Adrenergic beta-Antagonists/pharmacokinetics , Infant, Premature , Propranolol/pharmacokinetics , Administration, Oral , Adrenergic beta-Antagonists/administration & dosage , Female , Humans , Infant, Newborn , Male , Propranolol/administration & dosage
3.
Ital J Anat Embryol ; 116(3): 159-64, 2011.
Article in English | MEDLINE | ID: mdl-22852446

ABSTRACT

The functional anatomy of the respiratory system of dolphins has been scarcely studied. Specifically, the capacity of the system to resist pressure changes during diving has not been fully understood. Here we shortly describe the upper respiratory tract of dolphins based on three common species, the bottlenose dolphin Tursiops truncatus, the Risso's dolphin Grampus griseus, and the striped dolphin Stenella coeruleoalba. We emphasize the keymorphological features that represent evolutionary adaptations to life in the water, and, furthermore, also present a model of the tracheo-bronchial tree based on mechanical characterization and subsequent computational simulation of its biomechanical behaviour. Comparisons with the goat allowed us to determine how different structures may respond to diving-related pressure.


Subject(s)
Adaptation, Physiological/physiology , Diving/physiology , Dolphins/anatomy & histology , Respiratory Physiological Phenomena , Respiratory System/anatomy & histology , Animals , Aquatic Organisms/physiology , Biological Evolution , Dolphins/physiology , Species Specificity
4.
Apoptosis ; 11(5): 829-43, 2006 May.
Article in English | MEDLINE | ID: mdl-16534550

ABSTRACT

Most antitumour agents with cytotoxic properties induce apoptosis. The lipophilic compound euplotin C, isolated from the ciliate Euplotes crassus, is toxic to a number of different opportunistic or pathogenic microorganisms, although its mechanism of action is currently unknown. We report here that euplotin C is a powerful cytotoxic and pro-apoptotic agent in mouse AtT-20 and rat PC12 tumour-derived cell lines. In addition, we provide evidence that euplotin C treatment results in rapid activation of ryanodine receptors, depletion of Ca2+ stores in the endoplasmic reticulum (ER), the release of cytochrome c from the mitochondria, activation of caspase-12, and activation of caspase-3, leading to apoptosis. Intracellular Ca2+ overload is an early event which induces apoptosis and is parallelled by ER stress and the release of cytochrome c, whereas caspase-12 may be activated by euplotin C at a later stage in the apoptosis pathway. These events, either independently or concomitantly, lead to the activation of the caspase-3 and its downstream effectors, triggering the cell to undergo apoptosis. These results demonstrate that euplotin C may be considered for the design of cytotoxic and pro-apoptotic new drugs.


Subject(s)
Apoptosis/drug effects , Euplotes/chemistry , Euplotes/metabolism , Sesquiterpenes/chemistry , Sesquiterpenes/toxicity , Animals , Calcium/analysis , Calcium/metabolism , Caspase 3 , Caspases/analysis , Caspases/metabolism , Cells, Cultured , Chromatography, High Pressure Liquid , Cytosol/metabolism , DNA Fragmentation/drug effects , Euplotes/classification , Mass Spectrometry , Mice , Molecular Structure , Molecular Weight , PC12 Cells , Pituitary Neoplasms/pathology , Rats , Sesquiterpenes/isolation & purification , Spectrometry, Mass, Electrospray Ionization
5.
Neuroscience ; 138(2): 487-99, 2006.
Article in English | MEDLINE | ID: mdl-16388914

ABSTRACT

To complete a series of studies on the expression of substance P and neurokinin receptors in mammalian retinas, we investigated the occurrence of these molecules in developing mouse retinas and in retinas of mice with genetic deletion of the neurokinin 1 receptor, the preferred substance P receptor. Using semi-quantitative reverse transcription-polymerase chain reaction, we measured detectable levels of the gamma isoform of preprotachykinin A (a substance P precursor) mRNA at postnatal day 4. Neurokinin 1 receptor and neurokinin 3 receptor mRNAs were also detected at postnatal day 4. While gamma preprotachykinin A and neurokinin 1 receptor mRNA levels significantly increased up to eye opening (postnatal day 11), neurokinin 3 receptor mRNA levels remained constant throughout development. Substance P, neurokinin 1 receptor and neurokinin 3 receptor immunoreactivities were present at postnatal day 5. Substance P was in amacrine cells, neurokinin 1 receptor in developing amacrine and bipolar cells and neurokinin 3 receptor in OFF-type cone bipolar cells. Interestingly, a transient increase in the density of neurokinin 1 receptor immunoreactive processes was observed at eye opening in lamina 3 of the inner plexiform layer, suggesting a role of substance P and neurokinin 1 receptor in this developmental phase. However, in neurokinin 1 receptor knockout retinas, besides a significant increase of the gamma preprotachykinin A mRNA levels, no major changes were detected: neurokinin 3 receptor mRNA levels as well as substance P and neurokinin 3 receptor immunostainings were similar to wild types. Together with previous studies, these observations indicate that there are major differences in neurokinin 1 receptor expression patterns among developing mammalian retinas. The observations in neurokinin 1 receptor knockout mice may not be applicable to rats or rabbits, and substance P and neurokinin 1 receptor may play different developmental roles in different species.


Subject(s)
Receptors, Neurokinin-1/deficiency , Receptors, Neurokinin-1/genetics , Receptors, Neurokinin-3/genetics , Retina/physiology , Substance P/genetics , Aging , Animals , Base Sequence , Cyclophilins/genetics , DNA Primers , Gene Expression Regulation, Developmental , Mice , Mice, Knockout , Peptidylprolyl Isomerase/genetics , RNA, Messenger/genetics , Retina/growth & development
6.
Histol Histopathol ; 20(2): 615-32, 2005 04.
Article in English | MEDLINE | ID: mdl-15736065

ABSTRACT

The somatostatinergic system of the retina has been investigated in a variety of studies. A considerable amount of experimental evidence is available concerning the patterns of expression of somatostatin (SRIF) and its receptors in vertebrate retinas. However the functional roles of this peptidergic system in retinal physiology are far from being elucidated. Nonetheless, data have been provided concerning the regulatory action of SRIF on the excitability of different retinal cell types and on the modulation of ion channels in different vertebrate retinas. The present review is focused on recent and unpublished investigations of the mouse retina relative to the involvement of specific SRIF receptors in the regulation of ion channels and transmitter release, the transduction pathways coupled to SRIF receptors, and the mechanisms regulating the expression of SRIF and its receptors as derived from studies in transgenic animal models. In these models, altered expression levels of SRIF or of specific SRIF receptors have also been found to affect the morphology of retinal cell types (namely the rod bipolar cells) and to result in functional alterations at the level of both ion channel regulation and transmitter release. These new pieces of evidence constitute an important step forward in the understanding of the functional actions of the retinal somatostatinergic system, although our current knowledge is far from being exhaustive. The ultimate goal of understanding SRIF functional actions in the retina is concerned with the possibility of using SRIF or its analogs as therapeutic agents to cure retinal diseases. Indeed, encouraging results are being obtained in clinical investigations focused on the use of SRIF analogs to treat diabetic retinopathy, a retinal disease with high social impact and originating as a complication of diabetes. The closing part of the present paper examines the evidence supporting SRIF as a promising therapeutic agent in this disease.


Subject(s)
Retina/metabolism , Retinal Diseases/drug therapy , Somatostatin/metabolism , Somatostatin/therapeutic use , Adenylyl Cyclases/metabolism , Angiogenesis Inhibitors/therapeutic use , Animals , Cyclic AMP/metabolism , Diabetic Retinopathy/drug therapy , Diabetic Retinopathy/metabolism , Diabetic Retinopathy/pathology , Humans , Ion Channels/drug effects , Mice , Mice, Transgenic , Models, Biological , Neovascularization, Pathologic , Nerve Degeneration , Neuroprotective Agents/therapeutic use , Neurotransmitter Agents/metabolism , Nitric Oxide/metabolism , Receptors, Somatostatin/metabolism , Retina/drug effects , Retina/physiology , Retinal Diseases/metabolism , Retinal Diseases/physiopathology , Signal Transduction , Somatostatin/physiology
7.
Int J Artif Organs ; 28(12): 1232-41, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16404700

ABSTRACT

A new model lung (ML), designed to reproduce the tracheal pressure vs. fluid flow relationship in animals undergoing total liquid ventilation (TLV) trials, was developed to be used as a mock bench test for neonatal TLV circuits. The ML is based on a linear inertance-resistance-compliance (LRC) lumped-parameter model of the respiratory system with different resistance values for inspiration (R insp ) or expiration (R exp ). The resistant element was set up using polypropylene hollow fibres packed inside a tube. A passive one-way valve was used to control the resistance cross-section area provided for the liquid to generate different values for R insp or R exp , each adjustable by regulating the active length of the respective fibre pack. The compliant element consists of a cylindrical column reservoir, in which bars of different diameter were inserted to adjust compliance (C). The inertial phenomena occurring in the central airways during TLV were reproduced by specifically dimensioned conduits into which the endotracheal tube connecting the TLV circuit to the ML was inserted. A number of elements with different inertances (L) were used to simulate different sized airways. A linear pressure drop-to-flow rate relationship was obtained for flow rates up to 5 l/min. The measured C (0.8 to 1.3 mL cmH2O (-1) kg(-1)), R insp (90 to 850 cmH2O s l(-1)), and R exp (50 to 400 cmH2O s l(-1)) were in agreement with the literature concerning animals weighing from 1 to 12 kg. Moreover, features observed in data acquired during in vivo TLV sessions, such as pressure oscillations due to fluid inertia in the upper airways, were similarly obtained in vitro thanks to the inertial element in the ML.


Subject(s)
Liquid Ventilation/instrumentation , Models, Structural , Animals , Equipment Design , In Vitro Techniques , Lung Compliance , Rabbits
8.
J Biomech ; 37(12): 1837-47, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15519592

ABSTRACT

Knowledge of the mechanical behaviour of immature tracheae is crucial in order to understand the effects exerted on central airways by ventilatory treatments, particularly of Total Liquid Ventilation. In this study, a combined experimental and computational approach was adopted to investigate the compliance and particularly collapsibility of preterm lamb tracheae in the range of pressure likely applied during Total Liquid Ventilation (-30 to 30 cmH2O). Tracheal samples of preterm lambs (n = 5; gestational age 120-130 days) were tested by altering transmural pressure from -30 to 30 cmH2O. Inflation (Si) and collapsing (Sc) compliance values were calculated in the ranges 0 to 10 cmH2O and -10 to 0 cmH2O, respectively. During the tests, an asymmetric behaviour of the DeltaV/V0 vs. P curves at positive and negative pressure was observed, with mean Si = 0.013 cmH2O(-1) and Sc = 0.053 cmH2O(-1). A different deformed configuration of the sample regions was observed, depending on the posterior shape of cartilaginous ring. A three-dimensional finite-element structural model of a single tracheal ring, based on histology measurements of the tested samples was developed. The model was parameterised in order to represent rings belonging to three different tracheal regions (craniad, median, caudal) and numerical analyses replicating the collapse test conditions were performed to evaluate the ring collapsibility at pressures between 0 and -30 cmH2O. Simulation results were compared to experimental data to verify the model's reliability. The best model predictions occurred at pressures -30 to -10 cmH2O. In this range, a model composed of median rings best interpreted the experimental data, with a maximum error of 2.7%; a model composed of an equal combination of all rings yielded an error of 12.6%.


Subject(s)
Fetus/physiology , Trachea/physiology , Animals , Biomechanical Phenomena , Compliance , Female , Fetus/anatomy & histology , Gestational Age , In Vitro Techniques , Liquid Ventilation , Models, Anatomic , Models, Biological , Pregnancy , Pressure , Sheep , Trachea/anatomy & histology
9.
Neuroscience ; 124(1): 147-60, 2004.
Article in English | MEDLINE | ID: mdl-14960347

ABSTRACT

We investigated the expression of the substance P (SP) receptor (the neurokinin 1 receptor, NK1 receptor) and SP functional effects in developing rabbit retinas. NK1 receptors in adult retinas were in a population of cone bipolar cells and in dopaminergic amacrine cells, as previously described. In contrast, at birth and at postnatal day (PND) 6, NK1 receptors were exclusively expressed by cholinergic amacrine and displaced amacrine cells. NK1 receptor expression in cholinergic cells was still observed at PND10 (eye opening), while at PND21 it was confined to cholinergic cells of the inner nuclear layer. Starting at PND10, NK1 receptors were also in bipolar cells and in dopaminergic amacrine cells. A fully mature NK1 receptor expression pattern was observed at PND35. Dopamine release was assessed in isolated retinas in the presence of SP, the NK1 receptor agonist GR73632 or the NK1 receptor antagonist GR82334. At PND35, extracellular dopamine was significantly increased by 10 microM SP or 0.01-100 microM GR73632, and it was decreased by 0.01-10 microM GR82334. No effects were detected in developing retinas up to PND21. Ca2+ imaging experiments were performed in single cholinergic cells identified by their "starburst" morphology in perinatal retinas. Intracellular Ca2+ levels were significantly increased by 1 microM SP or GR73632. This effect was reversibly inhibited by 1 microM GR82334. These data demonstrate that both NK1 receptor expression and SP physiological actions are developmentally regulated in the retina. SP neurotransmission in the immature retina may subserve developmental events, and SP is likely to represent an important developmental factor for the maturation of retinal neurons and circuitries.


Subject(s)
Receptors, Neurokinin-1/metabolism , Retina/growth & development , Retina/metabolism , Substance P/metabolism , Acetylcholine/metabolism , Amacrine Cells/metabolism , Animals , Calcium/metabolism , Dopamine/metabolism , Fluorescent Antibody Technique , Immunohistochemistry , Rabbits , Retina/cytology
10.
J Appl Biomater Biomech ; 2(3): 177-82, 2004.
Article in English | MEDLINE | ID: mdl-20803436

ABSTRACT

Knowledge of immature tracheae mechanical behavior is fundamental in understanding the effects exerted on the upper airways by tidal liquid ventilation (TLV). Particularly, negative pressure can take place along the airways during expiration, which can cause airway collapse and flow limitation; therefore, representing a critical issue in preterm infant patients, whose airways are less stiff than adult ones. In this study, we investigated the expiratory pressure drop vs flow relationship of isolated preterm lamb tracheal samples to determine their hydraulic resistance, collapse pressure and collapse flow rate; a liquid flow through the samples was obtained by applying negative pressure at the outlet (cephalad) extremity of the tra-cheal sample, while keeping the inlet (caudal) extremity at atmospheric pressure. Histological analyzes were performed on the tracheal samples after each test session, in order to examine the morphological structure of the tracheal wall. Flow resistance tests demonstrated progressive lumen narrowing at increasing pressure drop (∆P=P in -P out ). The flow rate increased with ∆P un-til a plateau was reached, and then decreased, describing the onset of a collapse phenomenon; however, complete occlusion was not reached. The tracheal samples demonstrated a similar behavior to that of a Starling resistor during the collapse phase: when a critical ∆P was reached, collapse was observed starting at the outlet region, which was subjected to the greatest negative pressure, then propagating towards the caudal direction. (Journal of Applied Biomaterials & Biomechanics 2004; 2: 177-82).

11.
Histol Histopathol ; 18(4): 1219-42, 2003 10.
Article in English | MEDLINE | ID: mdl-12973690

ABSTRACT

The present review examines various aspects of the developmental expression of neuropeptides and of their receptors in mammalian retinas, emphasizing their possible roles in retinal maturation. Different peptidergic systems have been investigated with some detail during retinal development, including substance P (SP), somatostatin (SRIF), vasoactive intestinal polypeptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), neuropeptide Y (NPY), opioid peptides and corticotrophin-releasing factor (CRF). Overall, the developmental expression of most peptides is characterized by early appearance, transient features and achievement of the mature pattern at the time of eye opening. Concerning possible developmental actions of neuropeptides, recent studies imply a role of SP in the modulation of cholinergic neurotransmission in early postnatal rabbit retinas, when cholinergic cells participate in the retinal spontaneous waves of activity. In addition, the presence of transient SRIF expressing ganglion cells and recent observations in SRIF receptor knock-out mice indicate variegated roles of this peptide in the development of the retina and of retinofugal projections. Furthermore, VIP and PACAP exert protective and growth-promoting actions that may sustain retinal neurons during their development, and opioid peptides may control cell proliferation in the developing retina. Finally, a peak in the expression of certain peptides, including VIP, NPY and CRF, is present around the time of eye opening, when the retina begins the analysis of structured visual information, suggesting important roles of these peptides during this delicate phase of retinal development. In summary, although the physiological actions of peptides during retinal development are far from being clarified, the data reviewed herein indicate promising perspectives in this field of study.


Subject(s)
Neuropeptides/biosynthesis , Receptors, Neuropeptide/biosynthesis , Retina/growth & development , Retina/metabolism , Animals , Humans , Mammals , Retina/cytology
12.
Neuropharmacology ; 44(5): 672-85, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12668053

ABSTRACT

The physiological actions of somatostatin-14 (SRIF: somatotrophin release inhibitory factor) receptor subtypes (sst(1)-sst(5)), which are endogenously expressed in growth cells (GC cells), have not yet been elucidated, although there is evidence that sst(2) receptors are negatively coupled to cytosolic free Ca(2+) concentration ([Ca(2+)](i)) and adenosine 3,5'-cyclic monophosphate (cAMP) accumulation. In addition, both sst(1) and sst(2) receptors are negatively coupled to growth hormone (GH) secretion in GC cells. Here we report on studies concerning the expression, the pharmacology and the functional role of native SRIF receptors in GC cells with the use of five nonpeptidyl agonists, highly selective for each of the SRIF receptors. Radioligand binding studies show that sst(2) and sst(5) receptors are present at different relative densities, while the presence of sst(3) and sst(4) receptors appears to be negligible. The absence of sst(1) receptor binding was unexpected in view of sst(1) receptor functional effects on GH secretion. This suggests very efficient receptor-effector coupling of a low-density population of sst(1) receptors. Functionally, only sst(2) receptors are coupled to the inhibition of [Ca(2+)](i) and cAMP accumulation and the selective activation of sst(5) receptors facilitates the stimulation of adenylyl cyclase activity through G(i/o) proteins. This effect was not observed when sst(2) and sst(5) receptors were simultaneously activated, suggesting that there is a functional interaction between sst(2) and sst(5) receptors. In addition, sst(1), sst(2) and sst(5) receptor activation inhibits GH release, further indicating that SRIF can modulate GH secretion in GC cells through mechanisms both dependent and independent on [Ca(2+)](i) and cAMP-dependent pathways. The present data suggest SRIF-mediated functional effects in GC cells to be very diverse and provides compelling arguments to propose that multiple native SRIF receptors expressed in the same cells are not simply redundant, but contribute to marked signalling diversity.


Subject(s)
Amides/pharmacology , Growth Hormone/metabolism , Naphthalenes/pharmacology , Receptors, Somatostatin/agonists , Receptors, Somatostatin/metabolism , Amides/metabolism , Animals , Dose-Response Relationship, Drug , Membrane Proteins , Naphthalenes/metabolism , Radioligand Assay , Rats , Tumor Cells, Cultured
13.
Naunyn Schmiedebergs Arch Pharmacol ; 363(6): 680-94, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11414663

ABSTRACT

Somatostatin (somatotropin release-inhibiting factor, SRIF) receptor subtypes are expressed by several retinal neurons, suggesting that SRIF acts at multiple levels of the retinal circuitry, although functional data on this issue are scarce. Of the SRIF receptors, the sst2A isoform is expressed by rod bipolar cells (RBCs) of the rabbit retina, and in isolated RBCs we studied the role of sst2 receptors in modulating both K+ current (IK) and the intracellular free [Ca2+] ([Ca2+]i) using both voltage-clamp and Ca2+-imaging techniques. SRIF and octreotide (a SRIF agonist that binds to sst2 receptors) inhibited that component of IK corresponding to the activation of large-conductance, Ca2+- and voltage-dependent K+ channels (IBK) and reduced the K+-induced [Ca2+]i accumulation, suggesting that SRIF effects on IBK may have been secondary to inhibition of Ca2+ channels. Octreotide effects on IBK or on [Ca2+]i accumulation were prevented by RBC treatment with L-Tyr8-Cyanamid 154806, a novel sst2 receptor antagonist, indicating that SRIF effects were mediated by sst2 receptor activation. The present data indicate that SRIF may modulate the information flow through second-order retinal neurons via an action predominantly at sst2 receptors, contribute to the proposition that SRIF be added to the growing list of retinal neuromodulators, and suggest that one of its possible roles in the retina is to regulate transmitter release from RBCs.


Subject(s)
Calcium/metabolism , Receptors, Somatostatin/physiology , Retinal Rod Photoreceptor Cells/drug effects , Somatostatin/pharmacology , Animals , Electrophysiology , Octreotide/pharmacology , Patch-Clamp Techniques , Rabbits , Receptors, Somatostatin/agonists , Retinal Rod Photoreceptor Cells/metabolism , Retinal Rod Photoreceptor Cells/pathology
14.
Brain Res Dev Brain Res ; 123(1): 67-80, 2000 Sep 30.
Article in English | MEDLINE | ID: mdl-11020551

ABSTRACT

In the retina, somatostatin (SRIF) acts as a neuromodulator by interacting with specific SRIF subtype (sst) receptors. Aim of this investigation was to determine the cellular localization of the sst2A receptor isoform in the postnatal rabbit retina. Receptor immunoreactivity was localized using the antiserum K-230, directed to the C-terminus of the human sst2A receptor. In the postnatal rabbit retina, sst2A receptors were abundantly expressed without significant regional differences. They were localized predominantly to rod bipolar cells, identified with a protein kinase C (PKC) antibody, to amacrine cells, some of which also containing tyrosine hydroxylase (TH), and to presumed rare horizontal cells. Quantitative analysis showed that sst2A-immunoreactive (-IR) bipolar and amacrine cells reached their maximum density and absolute number at the time of eye opening, when the expression pattern of sst2A receptors was similar to that in adult retinas. In the adult retina, 68% of the PKC-IR rod bipolars and 34% of the TH-IR amacrine cells were observed to also express sst2A receptors. The appearance of sst2A receptor immunolabeling prior to eye opening and the developmental profile of sst2A receptor expression are compatible with a role of SRIF in the maturation of retinal circuitries. The partial expression of sst2A receptors in PKC-IR rod bipolar cells and in TH-IR amacrine cells may suggest some type of heterogeneity within these cell populations.


Subject(s)
Receptors, Somatostatin/biosynthesis , Retina/growth & development , Retina/metabolism , Animals , Animals, Newborn , Image Interpretation, Computer-Assisted , Immunohistochemistry , Microscopy, Confocal , Microscopy, Fluorescence , Protein Kinase C/metabolism , Rabbits , Retinal Rod Photoreceptor Cells/metabolism
15.
Invest Ophthalmol Vis Sci ; 41(10): 3191-9, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10967083

ABSTRACT

PURPOSE: To detect mRNAs for somatostatin (somatotropin release-inhibiting factor [SRIF]) receptor subtypes 1 to 5 (sst(1) through sst(5)) in rabbit retinas by reverse transcription-polymerase chain reaction (RT-PCR) and to investigate the distribution of sst(1) by single- and double-label immunocytochemistry. METHODS: Semiquantitative RT-PCR using sst-specific primers from mouse sequences was performed. sst(1) was localized using a polyclonal antiserum directed to human sst(1) in cryostat sections of retinas from either normal or optic nerve-transected animals. Immunolabeled cell sizes and densities were measured in wholemounted retinas using computer-assisted image analysis. Double-label immunofluorescence was performed using the sst(1) antiserum in conjunction with monoclonal antibodies directed to SRIF, tyrosine hydroxylase (TH), parvalbumin (PV), or gamma-aminobutyric acid (GABA). RESULTS: With RT-PCR it was found that all five sst mRNAs were expressed in the rabbit retina, with highest levels of sst(1) mRNA. sst(1) immunolabeling was localized to amacrine cells in the proximal inner nuclear layer (INL) of all retinal regions and to displaced amacrine cells in the ganglion cell layer (GCL) of the ventral retina. Some large sst(1)-immunoreactive (IR) somata were also present in the GCL. They were not observed after optic nerve transection. Double-label immunofluorescence showed sst(1) expression by all TH-IR amacrine cells and by other amacrine cells that were neither PV-IR nor GABA-IR. In addition, sst(1) was expressed by all SRIF-containing displaced amacrine cells. CONCLUSIONS: All five sst mRNAs are expressed in the rabbit retina. The localization of sst(1) suggests that it may mediate SRIF actions onto amacrine (including dopaminergic) and sparse ganglion cells. sst(1) expression in SRIF-IR cells suggests that this receptor may also act as an autoreceptor.


Subject(s)
RNA, Messenger/metabolism , Receptors, Somatostatin/genetics , Retina/metabolism , Animals , Axotomy , Cell Count , Cell Size , DNA Primers/chemistry , Gene Expression , Immunoenzyme Techniques , Microscopy, Confocal , Neuroglia/metabolism , Optic Nerve/physiology , Parvalbumins/metabolism , Rabbits , Receptors, Somatostatin/metabolism , Retina/cytology , Reverse Transcriptase Polymerase Chain Reaction , Tyrosine 3-Monooxygenase/metabolism , gamma-Aminobutyric Acid/metabolism
16.
Br J Pharmacol ; 129(3): 471-84, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10711345

ABSTRACT

1. In rat pituitary tumour cells (GC cells), spontaneous oscillations of the intracellular concentration of Ca2+ ([Ca2+]i) induce growth hormone (GH) secretion that is inhibited by octreotide, a somatostatin (SRIF) agonist which binds to SRIF subtype (sst) receptor 2. The effects of its functional activation on the control of [Ca2+]i were investigated using fluorimetric measurements of [Ca2+]i. 2. SRIF decreases the basal [Ca2+]i and the [Ca2+]i rise in response to forskolin (FSK) through the inhibition of L-type voltage-dependent Ca2+ channels. 3. Pretreatment with octreotide or with L-Tyr8++ Cyanamid 154806, a sst2 receptor antagonist, abolishes the SRIF-induced inhibition of [Ca2+]i. Octreotide is known to operate through agonist-induced desensitization, while the antagonist operates through receptor blockade. 4. sst1 and sst2 receptor-immunoreactivities (-IRs) are localized to cell membranes. sst2, but not sst1 receptor-IR, internalizes after cell exposure to octreotide. 5. SRIF-induced inhibition of basal [Ca2+]i or FSK-induced Ca2+ entry is blocked by pertussis toxin (PTX). 6. FSK-induced cyclic AMP accumulation is only partially decreased by SRIF or octreotide, indicating that sst2 receptors are coupled to intracellular pathways other than adenylyl cyclase (AC) inhibition. 7. In the presence of H-89, an inhibitor of cyclic AMP-dependent protein kinase (PKA), SRIF-induced inhibition of basal [Ca2+]i is still present, although reduced in amplitude. 8. SRIF inhibits [Ca2+]i by activating sst2 receptors. Inhibition of AC activity is only partly responsible for this effect, and other transduction pathways may be involved.


Subject(s)
Calcium/metabolism , Cytosol/metabolism , Hormone Antagonists/pharmacology , Pituitary Gland/metabolism , Somatostatin/pharmacology , Animals , Cyclic AMP/metabolism , Cytosol/drug effects , Fluorescent Antibody Technique , Fluorometry , Immunohistochemistry , Membrane Potentials/physiology , Microscopy, Confocal , Pituitary Gland/cytology , Pituitary Gland/drug effects , Rats , Receptors, Somatostatin/drug effects , Receptors, Somatostatin/metabolism , Signal Transduction/drug effects , Tumor Cells, Cultured
17.
Vis Neurosci ; 16(6): 1015-28, 1999.
Article in English | MEDLINE | ID: mdl-10614584

ABSTRACT

Based on previous evidence that acetylcholine (ACh) and noradrenaline (NA) play a permissive role in developmental plasticity in the kitten visual cortex, we reinvestigated this topic in the postnatal visual cortex of rats with normal vision. In rats, the functional properties of visual cortical cells develop gradually between the second and the sixth postnatal week (Fagiolini et al., 1994). Cortical cholinergic depletion, by basal forebrain (BF) lesions at postnatal day (PD) 15 (eye opening), leads to a transient disturbance in the distribution of ocular dominance (Siciliano et al., 1997). In the present study, we investigated the development of visual cortical response properties following cytotoxic lesions of the locus coeruleus (LC) alone or in combination with lesions of cholinergic BF. The main result is that early NA depletion impairs the orientation selectivity of cortical neurons, causes a slight increase of their receptive-field size, and reduces the signal-to-noise ratio of cell responses. Similar effects are obtained following NA depletion in adult animals, although the effects of adult noradrenergic deafferentation are significantly more severe than those obtained after early NA depletion. Additional cholinergic depletion causes an additional transient change in ocular-dominance distribution similarly to that obtained after cholinergic deafferentation alone. Comparisons between depletion of NA on the one hand and depletion of both NA and ACh on the other suggest that the effects of combined deafferentation on the functional properties studied result from simple linear addition of the effects of depleting each afferent system alone.


Subject(s)
Acetylcholine/physiology , Neurons, Afferent/physiology , Norepinephrine/physiology , Visual Cortex/physiology , Animals , Animals, Newborn , Choline O-Acetyltransferase/metabolism , Dominance, Cerebral/physiology , Electrophysiology , Immunoenzyme Techniques , Locus Coeruleus/drug effects , Locus Coeruleus/metabolism , Locus Coeruleus/pathology , Oxidopamine/toxicity , Prosencephalon/drug effects , Prosencephalon/metabolism , Prosencephalon/pathology , Quisqualic Acid/toxicity , Rats , Rats, Long-Evans , Serotonin/metabolism , Tyrosine 3-Monooxygenase/metabolism , Visual Cortex/growth & development
18.
Neurosci Lett ; 265(2): 123-6, 1999 Apr 16.
Article in English | MEDLINE | ID: mdl-10327184

ABSTRACT

In PC12 cells, somatostatin (SRIF) decreases the Ca2+ influx in response to high K+ through the inhibition of voltage-dependent Ca2+ channels. In the present study, we measured the intracellular Ca2+ concentration ( [Ca2+]i) following the application of SRIF-14 or its analogues which bind to different SRIF subtype (sst) receptors. Their application differentially reduces [Ca2+]i (octreotide > SRIF-14 > CGP23996 > BIM23056) in a dose-dependent manner. Pretreatment with a SRIF antagonist prevents the SRIF-induced inhibition of [Ca2+]i. These results suggest the involvement of specific membrane receptors and are in line with recent findings indicating the presence of receptor mRNAs on PC12 cells. Our results also exclude the possibility that SRIF interacts with opioid receptors and suggest that the SRIF-induced inhibition of [Ca2+]i is mediated by mechanisms involving PTX-sensitive G-proteins and PK-dependent pathways.


Subject(s)
Calcium/metabolism , Cytosol/metabolism , Somatostatin/pharmacology , Animals , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , GTP-Binding Proteins/drug effects , GTP-Binding Proteins/physiology , Octreotide/pharmacology , Oligopeptides/pharmacology , Osmolar Concentration , PC12 Cells/drug effects , PC12 Cells/metabolism , Rats , Somatostatin/antagonists & inhibitors , Virulence Factors, Bordetella/pharmacology
19.
Dev Psychobiol ; 33(4): 305-15, 1998 Dec.
Article in English | MEDLINE | ID: mdl-9846234

ABSTRACT

The role of the homing pigeon hippocampal formation was examined in the development of loft fidelity and landmark navigation. During the course of five summers, different groups of young pigeons (hippocampal-lesioned, control-lesioned, and unoperated controls) were given free flight experience followed by short distance training and experimental releases. In Experiment 1, a census of which loft each pigeon entered revealed that hippocampal lesioned pigeons displayed less loft fidelity than controls. In Experiment 2 and 3, the percent of young birds lost during their first summer of training and their first experimental release was examined. Despite displaying similarly good homeward-oriented vanishing bearings, significantly more hippocampal lesioned pigeons were lost compared to control groups. The results support the hypothesis that the homing pigeon hippocampal formation participates in the learning/operation of a spatial representation of local landmarks near the loft that can be used for loft recognition and navigation.


Subject(s)
Columbidae/physiology , Hippocampus/physiology , Homing Behavior/physiology , Orientation/physiology , Animals , Brain Mapping , Mental Recall/physiology
20.
Brain Res Dev Brain Res ; 111(2): 223-30, 1998 Dec 07.
Article in English | MEDLINE | ID: mdl-9838128

ABSTRACT

The rat pheochromocytoma cell line PC12 forms neurites in response to nerve growth factor (NGF), and it was also reported to extend processes in the presence of somatostatin (somatotropin release-inhibiting factor, SRIF), a neuroactive peptide that seems to act as a morphogenetic factor in the developing nervous system. In the present study, we re-evaluated the effects of SRIF on PC12 cell differentiation. Our results indicate that SRIF alone is ineffective in promoting neurite outgrowth. Instead, SRIF or its analogue, octreotide (a SRIF agonist on the receptor subtypes 2, 3 and 5), potentiates neurite extension induced by NGF. These results suggest that SRIF enhances neurite formation in PC12 cells without directly promoting neurite outgrowth. SRIF potentiation of NGF-induced neurite outgrowth persists at least in part in the presence of pertussis toxin (PTX), suggesting the involvement of PTX-insensitive G-proteins. In addition, protein kinase-dependent pathways are likely to mediate SRIF effects on NGF-induced differentiation.


Subject(s)
Hormone Antagonists/pharmacology , Neurites/physiology , Neurons/cytology , Neurons/drug effects , Somatostatin/pharmacology , Sulfonamides , Animals , Cell Differentiation/drug effects , Drug Interactions , Enzyme Inhibitors/pharmacology , GTP-Binding Proteins/metabolism , Indoles/pharmacology , Isoquinolines/pharmacology , Maleimides/pharmacology , Nerve Growth Factors/pharmacology , Neurites/chemistry , Neurites/enzymology , Neurofilament Proteins/metabolism , Neurons/ultrastructure , Octreotide/pharmacology , PC12 Cells , Pertussis Toxin , Protein Kinase Inhibitors , Protein Kinases/metabolism , Rats , Virulence Factors, Bordetella/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...